Alzheimer’s Drug Aduhelm Faces Crucial Medicare Decisionnews2021-12-31T21:39:22+00:00December 31st, 2021|The New York Times|
F.D.A. Plans to Allow 12- to 15-Year-Olds to Receive Pfizer Boostersnews2021-12-31T02:43:34+00:00December 31st, 2021|The New York Times|
Teva Pharmaceuticals Found Liable in Landmark Opioid Trialnews2021-12-30T23:06:33+00:00December 30th, 2021|The New York Times|
J. & J. Booster Protects Against Severe Omicron, Study Saysnews2021-12-30T10:45:18+00:00December 30th, 2021|The New York Times|
Una alternativa a las gafas: gotas para los ojosnews2021-12-28T11:00:07+00:00December 28th, 2021|The New York Times|
South Korea approves Pfizer’s coronavirus pill for emergency use.news2021-12-28T00:19:17+00:00December 28th, 2021|The New York Times|
Merck’s Covid Pill Is Authorized by F.D.A. for High-Risk Adultsnews2021-12-24T02:19:46+00:00December 24th, 2021|The New York Times|
Beneath a Covid Vaccine Debacle, 30 Years of Government Culpabilitynews2021-12-23T10:00:26+00:00December 23rd, 2021|The New York Times|
Walgreens and CVS Limit Purchases of At-Home Coronavirus Testsnews2021-12-23T04:03:53+00:00December 23rd, 2021|The New York Times|
F.D.A. Clears Pfizer’s Covid Pill for High-Risk Patients 12 and Oldernews2021-12-22T22:02:31+00:00December 22nd, 2021|The New York Times|